PTPRC and hepatocellular carcinoma: Moreover, transfer of CD45+EPCs from HCC tissue decreased survival (Figure 7E) and increased the incidence of MVI (p = 0.02092) in tumor-bearing mice; this effect was not observed following transfer of CD45+EPCs from the spleen (p = 0.505; Figure 7F).